Cargando…

Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force

The International Society for Biological Therapy of Cancer (iSBTc, recently renamed the Society for Immunotherapy of Cancer, SITC) hosted a one-day symposium at the National Institutes of Health on September 30, 2010 to address development and application of biomarkers in cancer immunotherapy. The s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butterfield, Lisa H, Disis, Mary L, Khleif, Samir N, Balwit, James M, Marincola, Francesco M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014892/ https://www.ncbi.nlm.nih.gov/pubmed/21138581 http://dx.doi.org/10.1186/1479-5876-8-130

Ejemplares similares

The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program
por: Balwit, James M, et al.
Publicado: (2011)

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery
por: Bedognetti, Davide, et al.
Publicado: (2011)

A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
por: Butterfield, Lisa H, et al.
Publicado: (2008)

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
por: Butterfield, Lisa H., et al.
Publicado: (2018)

Preamble to the 2015 SITC immunotherapy biomarkers taskforce
por: Butterfield, Lisa H, et al.
Publicado: (2015)

Announcing the Tumor Immunology and Biological Cancer Therapy section (edited by iSBTc) of the Journal of Translational Medicine
por: Romero, Pedro, et al.
Publicado: (2009)

Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule
por: Kaufman, Howard L., et al.
Publicado: (2016)

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)
por: Atkins, Michael B, et al.
Publicado: (2022)

Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
por: Tawbi, Hussein A, et al.
Publicado: (2023)

Correction: Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
Publicado: (2023)

Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting
por: Stroncek, David F, et al.
Publicado: (2013)

Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
por: Cesano, Alessandra, et al.
Publicado: (2018)

Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer
por: Lee, Belinda, et al.
Publicado: (2019)

Immune landscape and biomarkers for immuno-oncology in colorectal cancers
por: Bae, Jeong Mo, et al.
Publicado: (2020)

Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
por: Vafaizadeh, Vida, et al.
Publicado: (2020)

SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
por: Hu-Lieskovan, Siwen, et al.
Publicado: (2020)

Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast
por: Vranic, Semir, et al.
Publicado: (2020)

Immuno-oncology trends: preclinical models, biomarkers, and clinical development
por: Franklin, Maryland Rosenfeld, et al.
Publicado: (2022)

Germline genetic host factors as predictive biomarkers in immuno-oncology
por: Chat, Vylyny, et al.
Publicado: (2019)

Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
por: Gulley, James L., et al.
Publicado: (2017)

Editorial: Systems Biology Methods in Computational Immuno-Oncology
por: Rodin, Andrei S., et al.
Publicado: (2022)

Advances in immuno-oncology biomarkers for gastroesophageal cancer: Programmed death ligand 1, microsatellite instability, and beyond
por: Lin, Emily M, et al.
Publicado: (2018)

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
por: Marciscano, Ariel E., et al.
Publicado: (2018)

The evolving landscape of predictive biomarkers in immuno‐oncology with a focus on spatial technologies
por: Sadeghi Rad, Habib, et al.
Publicado: (2020)

Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
por: Asleh, Karama, et al.
Publicado: (2023)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era
por: Lee, Dae Ho
Publicado: (2018)

A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology
por: Sprooten, Jenny, et al.
Publicado: (2022)

Mismatch repair testing in breast cancer: the path to tumor-specific immuno-oncology biomarkers
por: Venetis, Konstantinos, et al.
Publicado: (2020)

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
por: Gnjatic, Sacha, et al.
Publicado: (2017)

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
por: Bedognetti, Davide, et al.
Publicado: (2019)

Optimization of fibrinogenolytic activity of Solanum tuberosum subtilisin-like protease (StSBTc-3) by response surface methodology
por: Pepe, Alfonso, et al.
Publicado: (2019)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
por: Emens, Leisha A, et al.
Publicado: (2021)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
por: Disis, Mary L, et al.
Publicado: (2023)

SITC 26(th) annual meeting – summary
por: Romano, Emanuela, et al.
Publicado: (2012)

Single-cell Analysis Technologies for Immuno-oncology Research: from Mechanistic Delineation to Biomarker Discovery
por: Bai, Zhiliang, et al.
Publicado: (2021)

Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019)

Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)

PD‐L1 and beyond: Immuno‐oncology in cytopathology
por: Iaccarino, Antonino, et al.
Publicado: (2021)

Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond
por: Gerard, C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aitpgfg6ne35dgj3plv43sit3j